Science, ethics, and the future of research into maternal infant transmission of HIV-1
- 1 March 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9155) , 832-835
- https://doi.org/10.1016/s0140-6736(98)10414-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention.American Journal of Public Health, 1998
- The debate over maternal-fetal HIV transmission prevention trials in Africa, Asia, and the Caribbean: racist exploitation or exploitation of racism?American Journal of Public Health, 1998
- Placebo controls in HIV perinatal transmission trials: a South African's viewpoint.American Journal of Public Health, 1998
- HIV research, ethics, and the developing world.American Journal of Public Health, 1998
- The prevention of perinatal HIV transmission in the less-developed world.American Journal of Public Health, 1998
- The Highest Attainable Standard: Ethical Issues in AIDS VaccinesScience, 1998
- Pragmatism in codes of research ethicsThe Lancet, 1998
- Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus–1 transmission in FranceThe Journal of Pediatrics, 1997
- Health, Nutrition and Population Sector StrategyPublished by World Bank ,1997
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994